LD 1117 Maine Senate · 130th Legislature (2021-2022)

An Act To Prevent Excessive Prices For Prescription Drugs

Bill status failed 4 of 5 stages cleared
Introduction
Mar 2021
Committee Review
Jun 2021
House Passage
Jun 2021
Senate Passage
Jun 2021
Governor
Introduced Mar 18, 2021 Last action Jul 19, 2021
Floor votes · House Jun 16, 2021

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
30
Key actions
8
Committee
5
Jul 19, 2021
Vetoed
LD 1117 In Senate, July 19, 2021, this Bill, having been returned by the Governor, together with objections to the same pursuant to the provisions of the Constitution of the State of Maine, after reconsideration, the Senate proceeded to vote on the question: "Shall this Bill become a law notwithstanding the objections of the Governor?" 20 and 14, accordingly it was the vote of the Senate that the Bill not become law and the VETO was SUSTAINED.
upper
Jun 17, 2021
Upper · Passed
PASSED TO BE ENACTED, in concurrence.
upper
Jun 17, 2021
Lower · Passed
PASSED TO BE ENACTED.
lower
Jun 16, 2021
Lower · Passed
Committee Amendment "B" (S-283) was READ and ADOPTED.
lower
Jun 16, 2021
Lower · Passed
On motion of Representative TEPLER of Topsham, REPORT A Ought to Pass as Amended was ACCEPTED.
lower
Jun 16, 2021
House · Passed
House Vote: pass (63-49-8)
house
Jun 15, 2021
Upper · Passed
Committee Amendment "B" (S-283) READ and ADOPTED
upper
Jun 15, 2021
Upper · Passed
On motion by Senator SANBORN of Cumberland The Report A Ought to Pass As Amended by Committee Amendment "B" (S-283) Report ACCEPTED
upper
Jun 14, 2021
Legislature · Passed
Reported Out - OTP-AM/OTP-AM/ONTP
legislature
1 primary · 8 co-sponsors

Sponsors